ANTI-TUMOR IMMUNITY AND ONCOMARKERS: A COMPREHENSIVE OVERVIEW
Keywords:
tumor immunology, the immune system, Innate Immunity, adaptive immunity, oncomarkers, diagnosis.Abstract
Cancer remains one of the leading causes of morbidity and mortality worldwide. Recent advances in immunology have led to a deeper understanding of the body's immune response to tumors, giving rise to the field of tumor immunology. Anti-tumor immunity refers to the immune system's ability to recognize and eliminate cancer cells. This article explores the mechanisms of anti-tumor immunity, the role of oncomarkers in cancer diagnosis and prognosis, and the potential for harnessing these responses in therapeutic strategies.
References
1. Jansen, C. S., and M. L. W. van der Burg, "The Role of Anti-Tumor Immunity in Cancer Treatment," Nature Reviews Clinical Oncology, vol. 15, no. 4, pp. 166-186, 2018.
2. Chen, D. S., and I. Mellman, "Elements of Cancer Immunity and the Immune System," Nature, vol. 542, no. 7640, pp. 347-353, 2017.
3. Topalian, S. L., et al., "Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy," Cancer Cell, vol. 27, no. 1, pp. 12-20, 2015.
4. Van den Eynde, B. J., and F. S. A. H. G. Roepman, "Oncomarkers in Cancer Diagnosis and Prognosis," Journal of Clinical Oncology, vol. 37, no. 36, pp. 123-129, 2019.
5. Riaz, N., et al., "Tumor Burden and the Role of Tumor Markers in the Prediction of Immune Response," Clinical Cancer Research, vol. 25, no. 4, pp. 1145-1152, 2019.
6. Schreiber, R. D., et al., "Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion," Science, vol. 331, no. 6024, pp. 1565-1570, 2011.
7. Karp, A. X., and A. D. O'Rourke, "Harnessing the Immune System to Treat Cancer," Nature Reviews Drug Discovery, vol. 14, no. 12, pp. 895-896, 2015.
8. Pardoll, D. M., "The Blockade of Immune Checkpoints in Cancer Immunotherapy," Nature Reviews Cancer, vol. 12, no. 4, pp. 252-264, 2012.
